Unicycive Therapeutics Receives FDA Complete Response Letter for Oxylanthanum Carbonate NDA
FDA did not raise concerns regarding the clinical efficacy or safety data of OLC, and no additional data was requested Unicycive Therapeutics, Inc. (NASDAQ:UNCY) MOUNTAIN VIEW, CA, UNITED STATES, July 1, 2026 /EINPresswire.com/ -- Unicycive …